86 related articles for article (PubMed ID: 22590693)
1. Simultaneous siRNA-mediated silencing of pairs of genes coding for enzymes involved in glycosaminoglycan synthesis.
Dziedzic D; Narajczyk M; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
Acta Biochim Pol; 2012; 59(2):293-8. PubMed ID: 22590693
[TBL] [Abstract][Full Text] [Related]
2. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
[TBL] [Abstract][Full Text] [Related]
3. Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease.
Dziedzic D; Wegrzyn G; Jakóbkiewicz-Banecka J
Eur J Hum Genet; 2010 Feb; 18(2):200-5. PubMed ID: 19690584
[TBL] [Abstract][Full Text] [Related]
4. UV irradiation-induced production of monoglycosylated biglycan through downregulation of xylosyltransferase 1 in cultured human dermal fibroblasts.
Jin CL; Oh JH; Han M; Shin MK; Yao C; Park CH; Jin ZH; Chung JH
J Dermatol Sci; 2015 Jul; 79(1):20-9. PubMed ID: 25936869
[TBL] [Abstract][Full Text] [Related]
5. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
[TBL] [Abstract][Full Text] [Related]
6. Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis.
Piotrowska E; Jakóbkiewicz-Banecka J; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
Acta Paediatr; 2009 Apr; 98(4):743-9. PubMed ID: 19046346
[TBL] [Abstract][Full Text] [Related]
7. Gene expression-targeted isoflavone therapy.
Węgrzyn A
IUBMB Life; 2012 Apr; 64(4):307-15. PubMed ID: 22362546
[TBL] [Abstract][Full Text] [Related]
8. Comparison of siRNA-mediated silencing of glycosaminoglycan synthesis genes and enzyme replacement therapy for mucopolysaccharidosis in cell culture studies.
Chmielarz I; Gabig-Cimińska M; Malinowska M; Banecka-Majkutewicz Z; Węgrzyn A; Jakobkiewicz-Banecka J
Acta Biochim Pol; 2012; 59(4):697-702. PubMed ID: 23251908
[TBL] [Abstract][Full Text] [Related]
9. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
[TBL] [Abstract][Full Text] [Related]
10. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
[TBL] [Abstract][Full Text] [Related]
11. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
12. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
13. Quantitative estimation of lysosomal storage in mucopolysaccharidoses by electron microscopy analysis.
Narajczyk M; Moskot M; Konieczna A
Acta Biochim Pol; 2012; 59(4):693-6. PubMed ID: 23230565
[TBL] [Abstract][Full Text] [Related]
14. A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses.
Wegrzyn G; Wegrzyn A; Tylki-Szymańska A
Med Hypotheses; 2004; 62(6):986-92. PubMed ID: 15142662
[TBL] [Abstract][Full Text] [Related]
15. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
[TBL] [Abstract][Full Text] [Related]
17. DICER-LIKE 4 is required for RNA interference and produces the 21-nucleotide small interfering RNA component of the plant cell-to-cell silencing signal.
Dunoyer P; Himber C; Voinnet O
Nat Genet; 2005 Dec; 37(12):1356-60. PubMed ID: 16273107
[TBL] [Abstract][Full Text] [Related]
18. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
[TBL] [Abstract][Full Text] [Related]
19. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
20. RNA interference (RNAi) in hematology.
Scherr M; Steinmann D; Eder M
Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
